About the Conference

Gastrosummit Organizers cordially invite you to attend the “13^th World Gastro Summit”, scheduled to take place on August 27–28, 2025, in Paris, France.

Gastrosummit 2025 offers a premier platform for sharing cutting-edge research, clinical advancements, and emerging technologies in gastroenterology and related disciplines. The summit features a dynamic scientific program that includes keynote lectures, plenary talks, symposiums, workshops, panel discussions, and poster presentations—all meticulously curated to meet the evolving needs of medical professionals and researchers.

This international gathering welcomes a diverse audience, including Gastroenterologists, Hepatologists, Endoscopists, Physicians, Microbiologists, Virologists, Pathologists, Oncologists, Surgeons, Toxicologists, Researchers, Students, Business Delegates, and Young Investigators from across the globe.

Join us in Paris for two days of enriching dialogue, professional networking, and exploration of the latest therapeutic strategies and innovations in gastrointestinal science.

Young Researcher Awards at Gastrosummit 2025

Gastrosummit 2025 is committed to recognizing and celebrating the exceptional achievements of young researchers, scientists, investigators, postgraduate students, postdoctoral fellows, trainees, and junior faculty members in the field. The Young Scientist Awards are designed to provide meaningful professional development opportunities for early-career academics by encouraging engagement with leading experts, facilitating knowledge exchange, and promoting discussions across all areas of Gastrosummit.

Young Research Forum (YRF) – Benefits:

• Recognition Certificate and Souvenir: Winners will receive a prestigious Young Scientist Award certificate and a commemorative souvenir.
• Oral Presentation Opportunity: Showcase your research on an international platform through oral presentations.
• Career Development: Learn about the latest advancements and career pathways through networking with peers and experts.
• Global Research Interaction: Engage with senior investigators from around the world and explore collaborative opportunities.
• Knowledge Enhancement: A valuable opportunity for young researchers to deepen their understanding of emerging research trends and areas within the field.

About the Organizer

Conference Series LLC Ltd stands at the forefront of global event organization, renowned for orchestrating high-impact academic, scientific, and industry-focused gatherings. From international conferences and symposia to specialized workshops and exhibitions, we bring together thought leaders from diverse sectors such as medicine, pharmaceuticals, engineering, technology, and business.

Backed by a robust network of 30,000+ editorial board members and strategic alliances with over 1,000 scientific societies, we successfully deliver 3,000+ global events annually across North America, Europe, the Middle East, and Asia. Our commitment to scholarly excellence is reflected in our 700+ open-access journals, where all proceedings are published and assigned a DOI through CrossRef, ensuring permanent accessibility and citation.

Reasons to Attend

• Forge Meaningful Connections: Build strong, cross-disciplinary relationships with researchers, innovators, and decision-makers from around the world.
• Drive Real-World Impact: Discover the latest breakthroughs and practical insights that can accelerate your research or business objectives.
• Access Influential Delegates: Engage directly with a curated audience of around 89 key stakeholders, including lab managers, policy influencers, and senior executives.
• Boost Visibility and Engagement: With 80% of attendees returning to exhibitor booths multiple times, the event fosters unmatched opportunities for networking and brand exposure.

Sessions &Tracks

Track 1: Gastroenterology

Gastroenterology focuses on the diagnosis and treatment of disorders affecting the digestive system, including the stomach, intestines, liver, pancreas, and gallbladder. Specialists in this field manage conditions ranging from acid reflux and IBS to Crohn’s disease and liver cirrhosis.

Relevant Associations:

American Gastroenterological Association

Canadian Society of Gastroenterology Nurses and Associates

European Society of Gastroenterology and Endoscopy Nurses

British Society of Pediatric Gastroenterology

Gastroenterological Society of Australia

Philippine Society of Gastroenterology

Track 2: Hepatology

Hepatology focuses on the diagnosis and treatment of liver diseases, including hepatitis, cirrhosis, fatty liver, liver cancer, and autoimmune disorders. Hepatologists use tools like blood tests, imaging, and biopsies to assess liver health and guide care. Treatments may include medication, lifestyle changes, or liver transplantation. As liver conditions become increasingly common, this field plays a critical role in early detection and effective management.

Relevant Associations:

Canadian Association of Gastroenterology

American Neurogastroenterology and Motility Society

European Society of Gastrointestinal Endoscopy

ESPGHAN

Gastroenterological Association of Thailand (GAT)

Track 3: Gastrointestinal Cancer

Gastrointestinal (GI) cancers encompass malignancies affecting the digestive tract, including the esophagus, stomach, liver, pancreas, colon, and rectum. These cancers present a significant global health burden, with diverse etiologist and varying prognoses. Treatment modalities include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy, often used in combination for optimal efficacy. Multidisciplinary approaches involving oncologists, surgeons, gastroenterologists, and other specialists are crucial for comprehensive care and improved patient outcomes.

Track 4: Advances in Gastrointestinal Cancer Management

Gastrointestinal (GI) cancers represent a diverse group of malignancies that affect organs within the digestive system, including the esophagus, stomach, liver, pancreas, colon, and rectum. These cancers are a major contributor to global cancer-related morbidity and mortality. Due to their varied etiologies and progression patterns, GI cancers require individualized treatment strategies. Current therapeutic approaches—such as surgical resection, chemotherapy, radiotherapy, immunotherapy, and molecularly targeted agents—are often combined to enhance outcomes. A multidisciplinary framework involving oncologists, gastroenterologists, surgeons, radiologists, and pathologists is essential for personalized treatment planning and improved patient survival.

Track 5: Insights into Gastrointestinal Pathology

Gastrointestinal pathology encompasses a broad spectrum of diseases affecting the digestive tract, including both inflammatory and neoplastic conditions. Disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, celiac disease, Crohn’s disease, ulcerative colitis, pancreatitis, cirrhosis, and GI cancers are among the most prevalent. Diagnostic protocols typically involve endoscopy, advanced imaging techniques, and histopathological evaluation of biopsies. Tailored treatment regimens may include pharmacotherapy, dietary adjustments, surgical interventions, or integrative therapies, depending on the specific pathology. Timely diagnosis and a patient-centered approach are pivotal for effective management and long-term disease control.

Track 6: Impact of COVID-19 on Gastroenterology Practice

The COVID-19 pandemic brought unprecedented changes to gastroenterology practices globally. Elective and non-urgent endoscopic procedures were deferred, straining diagnostic workflows and causing delays in treatment. The rapid adoption of telemedicine provided a partial solution for continued care, though challenges remain in evaluating complex GI conditions remotely. Practices were restructured to prioritize safety, with heightened infection control protocols, including strict hygiene practices and the use of personal protective equipment (PPE). Despite the disruption, the pandemic acted as a catalyst for innovation—accelerating digital integration and prompting the reevaluation of traditional care models in gastroenterology.

Track 7: Disorders of the Small Bowel and Colon

Diseases of the small intestine and colon span a range of inflammatory, infectious, and neoplastic conditions. Notable among these are inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis, as well as colorectal cancer, diverticulitis, and irritable bowel syndrome (IBS). Diagnostic tools such as colonoscopy, capsule endoscopy, and cross-sectional imaging aid in early and accurate identification. Management strategies are multifaceted—ranging from dietary modifications and pharmacologic therapy to surgical intervention for refractory cases. Advances in personalized medicine and biologic therapies are reshaping the landscape of small bowel and colonic disease treatment, improving patient quality of life and disease outcomes.

Track 8: Esophageal and Gastric Disease

This track focuses on a spectrum of conditions affecting the esophagus and stomach. Common esophageal disorders include Gastroesophageal Reflux Disease (GERD), where stomach acid flows back into the esophagus, causing heartburn and potentially damaging the esophageal lining. Long-term GERD may lead to Barrett’s esophagus, a precancerous change in the tissue lining. Gastric conditions range from gastritis (inflammation of the stomach lining) and peptic ulcers (sores in the stomach or duodenum) to gastric cancer. Symptoms can include abdominal pain, heartburn, nausea, and difficulty swallowing. Management strategies typically involve lifestyle modifications, pharmacologic therapy, and in advanced cases, surgical intervention. Early detection and appropriate treatment are key to preventing serious complications.

Track 9: Pancreatic and Biliary Disease

This track highlights diseases impacting the pancreas and bile ducts. Pancreatitis, or inflammation of the pancreas, may be acute or chronic, and is frequently triggered by gallstones or excessive alcohol use. Symptoms often include severe abdominal pain, nausea, and vomiting. Biliary disorders—such as gallstones, bile duct strictures, and cholangitis—can cause jaundice, digestive disturbances, and abdominal discomfort. Treatment approaches vary depending on the condition and may include medical management, dietary changes, or procedures like cholecystectomy or ERCP (Endoscopic Retrograde Cholangiopancreatography). Prompt diagnosis and intervention are essential to improving outcomes and preventing complications.

Track 10: The Microbiota Universe

Microbiota represent the vast and dynamic population of microorganisms—bacteria, viruses, fungi, and more—that reside in various environments including the human body, soil, air, and aquatic systems. Within the human body, the gut microbiota is especially significant, acting as a hidden regulator of digestion, immunity, metabolism, and even brain function. A disrupted microbial balance, or dysbiosis, has been increasingly associated with chronic illnesses such as obesity, IBD, and neurodegenerative disorders like Alzheimer’s disease. This evolving field is unlocking new opportunities for microbiome-targeted therapies, paving the way for personalized healthcare strategies.

Track 11: Abdominal Health & Frontline Medicine

This track focuses on the critical intersection of abdominal health and primary care medicine, where early detection and continuous management converge. From common gastrointestinal concerns like irritable bowel syndrome and abdominal discomfort to more complex digestive conditions, this field requires an integrated approach. Primary care physicians serve as the keystones—conducting initial diagnoses, prescribing treatments, and connecting patients to specialists when needed. Emphasizing holistic care, preventive screenings, and patient-centered management, this area plays a vital role in maintaining overall health and wellness.

Track 12: Insights into Celiac Disease

Celiac disease is a chronic autoimmune disorder in which gluten ingestion prompts an immune attack on the small intestine. This reaction damages the villi, the delicate structures responsible for absorbing essential nutrients. The consequences can be far-reaching—ranging from digestive discomfort and nutrient malabsorption to fatigue, anemia, and growth issues in children. As awareness grows, so does the research into non-dietary treatments, early diagnostics, and genetic predisposition, offering hope for improved quality of life for those affected.

Track 13: Advances in GI Endoscopy & Surgical Precision

Modern gastrointestinal care is deeply rooted in endoscopic innovation and surgical precision. Endoscopy allows clinicians to explore the inner workings of the GI tract in real time—identifying issues such as polyps, tumors, and bleeding sites with minimal invasiveness. Surgical interventions complement this by offering solutions for complex conditions through laparoscopic and robot-assisted techniques. Together, these technologies are transforming how we diagnose, treat, and recover from gastrointestinal diseases—reducing risks, shortening hospital stays, and improving patient outcomes.

Track 14: Paediatric Gastroenterology

Children aren't just small adults—their digestive systems have their own timelines, sensitivities, and surprises. Paediatric gastroenterology is a dynamic field dedicated to decoding the complex world of childhood gut health. From the discomforts of reflux in newborns to the challenges of managing IBD or celiac disease in teens, this specialty navigates a wide spectrum of conditions with precision and empathy. Specialists in this area bring not only medical expertise but also a deep understanding of developmental biology and family-centered care. Working closely with paediatricians, dietitians, and multidisciplinary teams, they craft care plans that grow with the child. With innovations in imaging, minimally invasive procedures, and personalized treatment approaches, the future of paediatric GI care is both hopeful and transformative.

Track 15: Gastrointestinal Pharmacotherapy

Behind every pill or protocol lies a story of chemistry meeting care. Gastrointestinal pharmacotherapy is where science tackles the spectrum of digestive woes—balancing acid, calming inflammation, restoring motility, and eradicating infection. Whether it’s a proton pump inhibitor easing the burn of GERD, or a biologic targeting chronic inflammation, every medication is a tool in a complex therapeutic arsenal. But it’s not just about what we prescribe—it’s about how, when, and for whom. This track explores the evolving landscape of drug development, precision dosing, and integrated treatment strategies that are reshaping GI care. As our understanding deepens, so too does our ability to tailor therapies that heal more effectively, with fewer side effects and greater patient outcomes.

Market Analysis

The global gastroenterology market was valued at USD 46.7 billion in 2023, driven by several key factors including the rising incidence of gastrointestinal disorders, an aging population, and technological advancements in diagnostic and therapeutic procedures. These trends have significantly contributed to the expansion of the market across the globe.

Looking forward, the market is projected to grow at a compound annual growth rate (CAGR) of 5.1% during the forecast period 2025–2032, reaching an estimated value of USD 72.9 billion by 2032.

Gastrosummit 2025: Introduction

Gastroenterology is a vital branch of medicine dedicated to the diagnosis, treatment, and management of disorders affecting the digestive tract, which includes the esophagus, stomach, small and large intestines, liver, gallbladder, pancreas, and rectum. Specialists in this field, known as gastroenterologists, are equipped to manage a wide range of conditions such as:

Gastroesophageal reflux disease (GERD)

Irritable bowel syndrome (IBS)

Inflammatory bowel diseases (IBD) like Crohn’s disease and ulcerative colitis

Liver diseases including hepatitis

Gastrointestinal cancers

Importance in Global Healthcare

Gastroenterology plays a critical role in global healthcare due to the growing prevalence of lifestyle-related disorders, aging populations, and increased public awareness surrounding digestive health. Gastrointestinal disorders are among the leading causes of medical consultations, hospital admissions, and disability worldwide, highlighting the importance of continued innovation and research in this field.